Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma

RNA interference (RNAi) is one of the most promising methods for the treatment of malignant tumors. However, developing an efficient biocompatible delivery vector for small interfering RNA (siRNA) remains a challenging issue. This study aimed to prepare a non-viral tumor-targeted carrier, named RGDf...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Bioact Mater
Egile Nagusiak: Xia, Yu, Tang, Guoyi, Chen, Yi, Wang, Changbing, Guo, Min, Xu, Tiantian, Zhao, Mingqi, Zhou, Yongjian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: KeAi Publishing 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658325/
https://ncbi.nlm.nih.gov/pubmed/33210026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bioactmat.2020.10.019
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak